Amarin Corporation Plc is a pharmaceutical company specializing in the development and commercialization of therapeutics for cardiovascular diseases. With a focus on the treatment of high triglyceride levels, Amarin is at the forefront of providing innovative solutions with their leading product, Vascepa. The company’s commitment to scientific research and dedication to improving patients’ lives sets them apart in the pharmaceutical industry.
